Insights on the Human Liver Models Global Market to 2028 - Strong Focus on Drug Discovery Activities Presents Opportunities - ResearchAndMarkets.com

The "Human Liver Models Market Forecast to 2028 - COVID-19 Impact and Global Analysis" report has been added to ResearchAndMarkets.com's offering.

The human liver models market is projected to reach US$ 508.26 million by 2028 from US$ 233.90 million in 2021; it is expected to grow at a CAGR of 11.7% from 2021 to 2028.

The market's growth is primarily attributed to the increasing prevalence of liver diseases and the growing focus on developing alternatives for animal testing models. Moreover, technological advancements in organ printing are expected to foster market growth during the forecast period. However, the high costs of human liver models and issues with incorporating liver models into existing workflow are hindering the market growth. The COVID-19 pandemic in North America had a significant impact on the US. The rapid rise in reported COVID-19 cases in the US has necessitated widespread changes in healthcare practices across the country. COVID-19-related issues have hampered liver transplantation in the region, posing a threat to the human liver models market over the anticipated period.

Based on type, the human liver models market is segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. The liver organoids segment is the largest shareholder in the market; however, the liver-on-a-chip segment is expected to register the highest CAGR during the forecast period. By application, the human liver models market is segmented into educational, drug discovery, and others.

The drug discovery segment holds the largest share of the human liver models market; however, the educational segment is anticipated to register the highest CAGR during the forecast period. By end user, the human liver models market is segmented into research institutes, pharmaceutical and biotechnology companies, and others. The pharmaceutical and biotechnology segment is the largest shareholder in the market. However, the research institutes segment is estimated to register the highest CAGR during the forecast period.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the human liver models market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global human liver models market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Market Dynamics

Drivers

• Increasing Prevalence of Liver Diseases
• Growing Focus on Developing Alternatives for Animal Testing

Restraints

• High Cost of Liver Models
• Issues with Incorporation of Liver Models into Existing Workflow

Opportunities

• Strong Focus on Drug Discovery Activities

Future Trends

• Technological Advancements in Organ Printing

Companies Mentioned

• THERMO FISHER SCIENTIFIC INC.
• Emulate, Inc.
• CN Bio Innovations,
• CYFUSE BIOMEDICAL K.K.
• MIMETAS BV
• InSphero
• BioIVT
• CELLINK
• Kerafast
• Cyprio
• Kirkstall
• ORGANOVO HOLDINGS INC

For more information about this report visit https://www.researchandmarkets.com/r/t52ytu

View source version on businesswire.com: https://www.businesswire.com/news/home/20220118006096/en/